N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression*
暂无分享,去创建一个
Manfred Wuhrer | André M. Deelder | Stephanie Holst | Wilma E. Mesker | W. Mesker | A. Deelder | Y. Rombouts | R. Tollenaar | M. Wuhrer | J. Garcia-Vallejo | S. V. van Vliet | C. Koeleman | Yoann Rombouts | G. V. van Pelt | Sandra J. van Vliet | Anna J. M. Deuss | Gabi W. van Pelt | Juan J. Garcia-Vallejo | Carolien A. M. Koeleman | Rob A. Tollenaar | S. Holst
[1] K. Khoo,et al. Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116. , 2008, Glycobiology.
[2] E. Miyoshi,et al. Fucosylation and gastrointestinal cancer. , 2010, World journal of hepatology.
[3] M. Engelse,et al. Activation of human endothelial cells by tumor necrosis factor‐α results in profound changes in the expression of glycosylation‐related genes , 2006, Journal of cellular physiology.
[4] F. dall’Olio,et al. UDP-GalNAc:NeuAc alpha 2,3Gal beta-R (GalNAc to Gal) beta 1,4-N-acetylgalactosaminyltransferase responsible for the Sda specificity in human colon carcinoma CaCo-2 cell line. , 1991, Biochemical and biophysical research communications.
[5] B Drewinko,et al. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. , 1976, Cancer research.
[6] W. Koltun,et al. Primary cell lines: false representation or model system? a comparison of four human colorectal tumors and their coordinately established cell lines. , 2010, International journal of clinical and experimental medicine.
[7] L. McDonnell,et al. N-glycosylation of Colorectal Cancer Tissues , 2012, Molecular & Cellular Proteomics.
[8] R. Hay,et al. Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. , 1983, Cancer genetics and cytogenetics.
[9] D. Santini,et al. Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. , 2007, Glycobiology.
[10] Y. van Kooyk,et al. Highly glycosylated tumour antigens: interactions with the immune system. , 2011, Biochemical Society transactions.
[11] K. Lam,et al. Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling. , 2014, Journal of proteome research.
[12] C. Sander,et al. Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.
[13] J. Hardcastle,et al. Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.
[14] Pauline M Rudd,et al. Glycans as cancer biomarkers. , 2012, Biochimica et biophysica acta.
[15] I. Lai,et al. β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer. , 2014, Carcinogenesis.
[16] Yehia Mechref,et al. Identifying cancer biomarkers by mass spectrometry‐based glycomics , 2012, Electrophoresis.
[17] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[18] J. Gu,et al. A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. , 2009, Journal of proteome research.
[19] Peng Gao,et al. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. , 2013, Analytical chemistry.
[20] Magnus Palmblad,et al. MassyTools: A High-Throughput Targeted Data Processing Tool for Relative Quantitation and Quality Control Developed for Glycomic and Glycoproteomic MALDI-MS. , 2015, Journal of proteome research.
[21] S. Rockwell. In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer. , 1980, The British journal of cancer. Supplement.
[22] R. Christopherson,et al. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies. , 2014, Journal of proteomics.
[23] Y. Rombouts,et al. Glycosylation characteristics of colorectal cancer. , 2015, Advances in cancer research.
[24] N. Packer,et al. Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. , 2014, Journal of proteome research.
[25] R. Sandberg,et al. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Chen,et al. DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin. , 1995, Cancer genetics and cytogenetics.
[27] Ying Liu,et al. Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1 , 2009, Proceedings of the National Academy of Sciences.
[28] W. Bodmer,et al. Cancer stem cells from colorectal cancer-derived cell lines , 2010, Proceedings of the National Academy of Sciences.
[29] Raquel Chaves,et al. The Importance of Cancer Cell Lines as in vitro Models in Cancer Methylome Analysis and Anticancer Drugs Testing , 2013 .
[30] W. Bodmer,et al. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] Manfred Wuhrer,et al. Mass spectrometric glycan rearrangements. , 2011, Mass spectrometry reviews.
[32] P. Rudd,et al. Altered Glycosylation in Tumours Focused to Cancer Diagnosis , 2009, Disease markers.
[33] Naoyuki Taniguchi,et al. Functional roles of N‐glycans in cell signaling and cell adhesion in cancer , 2008, Cancer science.
[34] E. Steenvoorden,et al. 2‐Picoline‐borane: A non‐toxic reducing agent for oligosaccharide labeling by reductive amination , 2010, Proteomics.
[35] C. Haglund,et al. N-glycomic Profiling as a Tool to Separate Rectal Adenomas from Carcinomas* , 2014, Molecular & Cellular Proteomics.
[36] S. von Kleist,et al. Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. , 1975, Journal of the National Cancer Institute.
[37] André M Deelder,et al. Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. , 2011, Analytical chemistry.
[38] J. Garcia-Vallejo,et al. Approach for defining endogenous reference genes in gene expression experiments. , 2004, Analytical biochemistry.
[39] W. Bodmer,et al. Cancer cell lines for drug discovery and development. , 2014, Cancer research.
[40] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[41] Z. Li,et al. Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.
[42] H. Matsumoto,et al. Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy , 2012, Biomolecules.
[43] L. Aaltonen,et al. Villin expression is frequently lost in poorly differentiated colon cancer. , 2012, The American journal of pathology.
[44] R. Cummings,et al. Antibodies and Lectins in Glycan Analysis , 2009 .
[45] R. Kannagi,et al. Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis , 2004, Cancer science.
[46] Shuai Jiang,et al. A novel lectin from Agrocybe aegerita shows high binding selectivity for terminal N-acetylglucosamine , 2012, The Biochemical journal.
[47] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[48] V. Sandig,et al. Rapid analysis of cell surface N-glycosylation from living cells using mass spectrometry. , 2014, Journal of proteome research.
[49] M. Mortuaire,et al. B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract. , 2014, The international journal of biochemistry & cell biology.
[50] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[51] D. Schaffer,et al. Extensive Determination of Glycan Heterogeneity Reveals an Unusual Abundance of High Mannose Glycans in Enriched Plasma Membranes of Human Embryonic Stem Cells* , 2011, Molecular & Cellular Proteomics.
[52] Adam Ertel,et al. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells , 2006, Molecular Cancer.
[53] R. Takimoto,et al. Fucosylated TGF-β receptors transduces a signal for epithelial–mesenchymal transition in colorectal cancer cells , 2013, British Journal of Cancer.
[54] S. Gringhuis,et al. Gene expression analysis of glycosylation-related genes by real-time polymerase chain reaction. , 2006, Methods in molecular biology.
[55] E. Suh,et al. The role of Cdx proteins in intestinal development and cancer , 2004, Cancer biology & therapy.
[56] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[57] F. dall’Olio,et al. UDP-Ga1NAc:NeuAcα2,3Galβ-R (GaINAc to Gal) β1,4-N-acetyl-galactosaminyltransferase responsible for the Sda specificity in human colon carcinoma CaCo-2 cell line , 1991 .
[58] Heather Lynaugh,et al. A cost-effective plate-based sample preparation for antibody N-glycan analysis. , 2013, Journal of chromatography. A.
[59] André M Deelder,et al. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. , 2014, Analytical chemistry.
[60] A. Jemal,et al. Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[61] J. Morgado-Díaz,et al. N‐glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells , 2012, Journal of cellular biochemistry.